跳至主要内容
临床试验/IRCT20110809007265N12
IRCT20110809007265N12招募中3 期

Comparison of the effectiveness of hypericum perforatum with placebo in appetite control in obese and overweight individuals

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • BMI 24.9 to 39.9
  • Women 18 years to premenopausal and men 18 to 60 years old
  • Consent to participate in the study
  • History of at least one monotherapy failure

排除标准

  • Hypothyroidism, Cushing's syndrome, cancer, liver or kidney failure
  • Psychiatric disorders associated with eating like anorexia nervosa and hyperorexia
  • Using drugs effective on weight and metabolism in the previous month
  • Using drugs that interfere with Hypericum perforatum such as protease inhibitors, amiodarone, anticoagulants, cyclophosphamide, cyclosporine, monoamine oxidase inhibitors, phenytoin, tacrolimus, tamoxifen and trazodone drug
  • Drug abuser or alcoholism
  • Breast-feeding, pregnancy or planning a pregnancy during the next two months
  • Pacemaker and any metal device inside the body due to the use of Bioelectrical Impedance Analyzer
  • Disability to do recommended physical activity
  • Allergy to hypericum perforatum

研究者

相似试验

Effect of hypericum perforatum in obesity | 临床试验